The Global Pulmonary Hypertension Drugs Market is estimated to be valued at USD 8.10 Bn in 2024 and is expected to reach USD 15.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.12% from 2024 to 2031. https://www.writerscafe.org/kajalpatil/blogs/Pulmonary-Hypertension-Drugs-Market-is-Anticipated-to-Witness-High-Growth-Owing-to-Rising-Prevalence-of-Pulmonary-Hypertension-Diseases/247346/